UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women

Neurobiology of aging, 2015-06, Vol.36 (6), p.2053-2059

2015

Volltextzugriff (PDF)

Clinical subtypes of premenstrual syndrome and responses to sertraline treatment

Obstetrics and gynecology (New York. 1953), 2011-12, Vol.118 (6), p.1293-1300

2011

Volltextzugriff (PDF)

Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: Results from the pelvic inflammatory disease evaluation and clinical health (peach) randomized trial

American journal of obstetrics and gynecology, 2002-05, Vol.186 (5), p.929-937

2002

Volltextzugriff (PDF)

Outcomes following fibroid expulsion after uterine artery embolization

Journal of vascular and interventional radiology, 2011-11, Vol.22 (11), p.1586-1593

2011

Volltextzugriff (PDF)

Male Axillary Extracts Contain Pheromones that Affect Pulsatile Secretion of Luteinizing Hormone and Mood in Women Recipients

Biology of reproduction, 2003-06, Vol.68 (6), p.2107-2113

2003

Volltextzugriff (PDF)

Continuous or Intermittent Dosing With Sertraline for Patients With Severe Premenstrual Syndrome or Premenstrual Dysphoric Disorder

The American journal of psychiatry, 2004-02, Vol.161 (2), p.343-351

2004

Volltextzugriff (PDF)

A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder

The journal of clinical psychiatry, 2005-06, Vol.66 (6), p.769-773

2005

Volltextzugriff (PDF)

Endometritis does not predict reproductive morbidity after pelvic inflammatory disease

American journal of obstetrics and gynecology, 2003-01, Vol.188 (1), p.141-148

2003

Volltextzugriff (PDF)

A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome

JAMA : the journal of the American Medical Association, 1995-07, Vol.274 (1), p.51

1995

Volltextzugriff (PDF)

Douching and Endometritis: Results From the PID Evaluation and Clinical Health (PEACH) Study

Sexually transmitted diseases, 2001-04, Vol.28 (4), p.240-245

2001

Volltextzugriff (PDF)

Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study

Journal of women's health & gender-based medicine, 2002-06, Vol.11 (5), p.459-464

2002

Volltextzugriff (PDF)

Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study

American journal of obstetrics and gynecology, 2001-07, Vol.185 (1), p.121-127

2001

Volltextzugriff (PDF)

Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents

Obstetrics and gynecology (New York. 1953), 1998-04, Vol.91 (4), p.609-614

1998

Volltextzugriff (PDF)

Predictors of response to sertraline treatment of severe premenstrual syndromes

The journal of clinical psychiatry, 2000-08, Vol.61 (8), p.579-584

2000

Volltextzugriff (PDF)

A pilot naturalistic follow-up of extended sertraline treatment for severe premenstrual syndrome

Journal of clinical psychopharmacology, 2004-06, Vol.24 (3), p.351-353

2004

Volltextzugriff (PDF)

Ineffectiveness of progesterone suppository treatment for premenstrual syndrome

JAMA : the journal of the American Medical Association, 1990-07, Vol.264 (3), p.349

1990

Volltextzugriff (PDF)

Male Axillary Extracts Contain Pheromones that Affect Pulsatile Secretion of Luteinizing Hormone and Mood in Women Recipients1

Biology of reproduction, 2003-06, Vol.68 (6), p.2107-2113

2003

Volltextzugriff (PDF)

Fluvoxamine for premenstrual dysphoric disorder: a pilot study

The journal of clinical psychiatry, 1996, Vol.57 Suppl 8, p.56

1996

Volltextzugriff (PDF)

Oral contraceptives: mechanism of action, dosing, safety, and efficacy

Cutis (New York, N.Y.), 2008-01, Vol.81 (1 Suppl), p.19

Sondheimer, Steven J

2008

Volltextzugriff (PDF)

INFLUENCES OF HORMONE REPLACEMENT THERAPY ON OLFACTORY AND COGNITIVE FUNCTION IN THE MENOPAUSE

Neurobiology of aging, 2015-03, Vol.36 (6), p.2053-2059

2015

Volltextzugriff (PDF)

Efficacy and safety of venlafaxine for premenstrual dysphoric disorder

Obstetrics and gynecology (New York. 1953), 2001-05, Vol.97 (5), p.S9-S10

Freeman, E

2001

Volltextzugriff (PDF)

Can we predict who will experience recurrent vasomotor symptoms after stopping hormone therapy?

Menopause (New York, N.Y.), 2010-01, Vol.17 (1), p.10-11

2010

Volltextzugriff (PDF)

Torsion of the Uterine Adnexa: Pathologic Correlations and Current Management Trends

Obstetrical & gynecological survey, 2001-02, Vol.56 (2), p.84-85

2001

Volltextzugriff (PDF)

Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease

American journal of obstetrics and gynecology, 2001-04, Vol.184 (5), p.856-864

2001

Volltextzugriff (PDF)

Assessment of Implanon™ insertion and removal

Contraception (Stoneham), 2008-11, Vol.78 (5), p.409-417

2008

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(103)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(66)
Female
(60)
Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Adult
(40)
Biological And Medical Sciences
(30)
Medical Sciences
(29)
Adolescent
(25)
Obstetrics & Gynecology
(25)
Premenstrual Syndrome - Drug Therapy
(18)
Middle Aged
(16)
Pregnancy
(16)
Psychiatry
(14)
Gynecology. Andrology. Obstetrics
(13)
Pharmacology. Drug Treatments
(13)
Double-Blind Method
(12)
Treatment Outcome
(12)
Drug Administration Schedule
(11)
Premenstrual Syndrome - Psychology
(11)
Follow-Up Studies
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women

Clinical subtypes of premenstrual syndrome and responses to sertraline treatment

Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: Results from the pelvic inflammatory disease evaluation and clinical health (peach) randomized trial

Outcomes following fibroid expulsion after uterine artery embolization

Male Axillary Extracts Contain Pheromones that Affect Pulsatile Secretion of Luteinizing Hormone and Mood in Women Recipients

Continuous or Intermittent Dosing With Sertraline for Patients With Severe Premenstrual Syndrome or Premenstrual Dysphoric Disorder

A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder

Endometritis does not predict reproductive morbidity after pelvic inflammatory disease

A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome

Douching and Endometritis: Results From the PID Evaluation and Clinical Health (PEACH) Study

Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study

Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study

Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents

Predictors of response to sertraline treatment of severe premenstrual syndromes

A pilot naturalistic follow-up of extended sertraline treatment for severe premenstrual syndrome

Ineffectiveness of progesterone suppository treatment for premenstrual syndrome

Male Axillary Extracts Contain Pheromones that Affect Pulsatile Secretion of Luteinizing Hormone and Mood in Women Recipients1

Fluvoxamine for premenstrual dysphoric disorder: a pilot study

Oral contraceptives: mechanism of action, dosing, safety, and efficacy

INFLUENCES OF HORMONE REPLACEMENT THERAPY ON OLFACTORY AND COGNITIVE FUNCTION IN THE MENOPAUSE

Efficacy and safety of venlafaxine for premenstrual dysphoric disorder

Can we predict who will experience recurrent vasomotor symptoms after stopping hormone therapy?

Torsion of the Uterine Adnexa: Pathologic Correlations and Current Management Trends

Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease

Assessment of Implanon™ insertion and removal

Suchergebnisse filtern